Mirae Asset Securities (Usa) Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Mirae Asset Securities (Usa) Inc.
- $3.27 Trillion
- Q2 2025
A detailed history of Mirae Asset Securities (Usa) Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Securities (Usa) Inc. holds 13,034 shares of ALNY stock, worth $5.67 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
13,034Holding current value
$5.67 Million% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
746Shares Held
110MCall Options Held
966KPut Options Held
841K-
Capital World Investors Los Angeles, CA16.7MShares$7.29 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$5.68 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.15 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$3.11 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.92 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $53.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...